PatisiranMeSH Supplementary Concept

https://ansm.sante.fr/tableau-acces-derogatoire/onpattro
2024
false
false
false
France
French
patisiran
drug information
guidelines for drug use
infusions, intravenous
Wild type ATTR amyloidosis
Hereditary ATTR amyloidosis
Cardiac ATTR Amyloidosis
amyloidosis
Transthyretin

---
https://ansm.sante.fr/tableau-marr/patisiran
2023
false
false
false
France
French
risk management
patisiran
patisiran
guidelines for drug use
patisiran
infusions, intravenous
Drug-Related side effects and adverse reactions
patient education handout
Adverse reaction caused by drug or medicament administered by infusion (disorder)
Infusion Site Reaction
Infusion Site Reaction
signs and symptoms

---
https://www.has-sante.fr/jcms/p_3146853/fr/onpattro
2020
false
false
false
France
patisiran
patisiran
amyloidosis, hereditary, Transthyretin-Related
treatment outcome
infusions, intravenous
adult
insurance, health, reimbursement
evaluation of the transparency committee
rna, small interfering
amyloid neuropathies, familial

---
https://www.has-sante.fr/portail/jcms/c_2912140/fr/onpattro
https://www.has-sante.fr/portail/jcms/c_2912140/en/onpattro-patisiran-medicament-du-systeme-nerveux
2019
false
true
false
false
France
French
treatment outcome
patisiran
orphan drug production
adult
amyloidosis, hereditary, Transthyretin-Related
infusions, intravenous
patisiran
evaluation of the transparency committee
polyneuropathies
Conventional release solution for injection (dose form)
rna, small interfering
guidelines for drug use
rna, small interfering
amyloid neuropathies, familial

---
https://www.has-sante.fr/jcms/c_2912140/fr/onpattro-patisiran-medicament-du-systeme-nerveux
2019
false
false
false
France
patisiran
patisiran
patisiran
guidelines for drug use
infusions, intravenous
orphan drug production
adult
amyloidosis, hereditary, Transthyretin-Related
treatment outcome
evaluation of the transparency committee
rna, small interfering
rna, small interfering
amyloid neuropathies, familial

---
https://www.ema.europa.eu/en/medicines/human/EPAR/onpattro
2018
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
patisiran
patisiran
drug approval
europe
orphan drug production
adult
amyloidosis, hereditary, Transthyretin-Related
infusions, intravenous
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
patisiran
drug evaluation, preclinical
rna, small interfering
rna, small interfering
amyloid neuropathies, familial

---